298 related articles for article (PubMed ID: 23024438)
1. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial.
Scheer FA; Morris CJ; Garcia JI; Smales C; Kelly EE; Marks J; Malhotra A; Shea SA
Sleep; 2012 Oct; 35(10):1395-402. PubMed ID: 23024438
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
[TBL] [Abstract][Full Text] [Related]
3. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
Ancoli-Israel S; Krystal AD; McCall WV; Schaefer K; Wilson A; Claus R; Rubens R; Roth T
Sleep; 2010 Feb; 33(2):225-34. PubMed ID: 20175406
[TBL] [Abstract][Full Text] [Related]
4. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
Luthringer R; Muzet M; Zisapel N; Staner L
Int Clin Psychopharmacol; 2009 Sep; 24(5):239-49. PubMed ID: 19584739
[TBL] [Abstract][Full Text] [Related]
5. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
[TBL] [Abstract][Full Text] [Related]
6. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial.
Chang YS; Lin MH; Lee JH; Lee PL; Dai YS; Chu KH; Sun C; Lin YT; Wang LC; Yu HH; Yang YH; Chen CA; Wan KS; Chiang BL
JAMA Pediatr; 2016 Jan; 170(1):35-42. PubMed ID: 26569624
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial.
Xu H; Zhang C; Qian Y; Zou J; Li X; Liu Y; Zhu H; Meng L; Liu S; Zhang W; Yi H; Guan J; Chen Z; Yin S
Sleep Med; 2020 Dec; 76():113-119. PubMed ID: 33157425
[TBL] [Abstract][Full Text] [Related]
8. The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).
Appleton RE; Jones AP; Gamble C; Williamson PR; Wiggs L; Montgomery P; Sutcliffe A; Barker C; Gringras P
Health Technol Assess; 2012; 16(40):i-239. PubMed ID: 23098680
[TBL] [Abstract][Full Text] [Related]
9. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
Rajaratnam SM; Polymeropoulos MH; Fisher DM; Roth T; Scott C; Birznieks G; Klerman EB
Lancet; 2009 Feb; 373(9662):482-91. PubMed ID: 19054552
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Sharpley AL
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009178. PubMed ID: 33189083
[TBL] [Abstract][Full Text] [Related]
11. Melatonin improves sleep quality of patients with chronic schizophrenia.
Shamir E; Laudon M; Barak Y; Anis Y; Rotenberg V; Elizur A; Zisapel N
J Clin Psychiatry; 2000 May; 61(5):373-7. PubMed ID: 10847313
[TBL] [Abstract][Full Text] [Related]
12. Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study.
Braam W; Didden R; Smits M; Curfs L
J Intellect Disabil Res; 2008 Mar; 52(Pt 3):256-64. PubMed ID: 18261024
[TBL] [Abstract][Full Text] [Related]
13. Melatonin for the promotion of sleep in adults in the intensive care unit.
Lewis SR; Pritchard MW; Schofield-Robinson OJ; Alderson P; Smith AF
Cochrane Database Syst Rev; 2018 May; 5(5):CD012455. PubMed ID: 29746721
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW;
PLoS Med; 2018 Jun; 15(6):e1002587. PubMed ID: 29912983
[TBL] [Abstract][Full Text] [Related]
15. Improvement of sleep quality in elderly people by controlled-release melatonin.
Garfinkel D; Laudon M; Nof D; Zisapel N
Lancet; 1995 Aug; 346(8974):541-4. PubMed ID: 7658780
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing.
Narayan AJ; Downey LA; Rose S; Di Natale L; Hayley AC
J Clin Sleep Med; 2024 May; 20(5):753-763. PubMed ID: 38174873
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009178. PubMed ID: 27851868
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial.
Grima NA; Rajaratnam SMW; Mansfield D; Sletten TL; Spitz G; Ponsford JL
BMC Med; 2018 Jan; 16(1):8. PubMed ID: 29347988
[TBL] [Abstract][Full Text] [Related]
19. Melatonin secretion related to side-effects of beta-blockers from the central nervous system.
Brismar K; Hylander B; Eliasson K; Rössner S; Wetterberg L
Acta Med Scand; 1988; 223(6):525-30. PubMed ID: 3291558
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of melatonin supplementation as an add-on treatment for infantile epileptic spasms syndrome: A randomized, placebo-controlled, double-blind trial.
Sun Y; Chen J; Shi X; Li Z; Wan L; Yan H; Chen Y; Wang J; Wang J; Zou L; Reiter R; Zhang B; Yang G
J Pineal Res; 2024 Jan; 76(1):e12922. PubMed ID: 37909654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
